Table 2.
case | A.1 | A.2 | B.1 | B.2 |
40 | A2 | A3 | B15 | B38 |
43 | A2 | A3 | B18 | B49 |
44 | A2 | A24 | B7 | B55 |
45 | A1 | A2 | B8 | B62 |
48 | A3 | A3 | B7 | B62 |
55 | A1 | A3 | B8 | B62 |
56 | A1 | A30 | B8 | B51 |
58 | A2 | A32 | B44 | B60 |
59 | A1 | A2 | B7 | B62 |
61* | A2 | Bw4 | Bw6 | |
63* | A2 | Bw4 | Bw6 | |
69 | A2 | A24 | B7 | B39 |
106* | A3 | Bw4 | Bw6 | |
108 | A2 | A68 | B51 | B53 |
109* | A3 | Bw4 | Bw6 | |
110 | A1 | A23 | B8 | B50 |
120 | A2 | A3 | B7 | B44 |
122 | A1 | A24 | B44 | B56 |
124* | A2 | Bw4 | ||
179 | A3 | A3 | B7 | B35 |
191 | A2 | A24 | B15 | B40 |
A.1, A.2, B.1 and B.2 indicate the different HLA A and B alleles. * HLA genotype was not known prior to tumor resection, phenotype based on flow cytometry of vim+ cells with mouse monoclonal antibodies (Table 1).